(GERN:Consolidated Issue Listed on NASDAQ Global Select )
Hoyoung Huh M.D., Ph.D.
Advisor, Bay City Capital LLC
|Age||Total Calculated Compensation||This person is connected to 107 board members in 7 different organizations across 10 different industries.|
See Board Relationships
Dr. Hoyoung Huh, M.D., Ph.D. serves as an Advisor at Bay City Capital LLC. Dr. Huh served as the Chief Executive Officer and President at BiPar Sciences, Inc. from March 3, 2008 to December 1, 2009. Dr. Huh served as the Chief Operating Officer and Head of the PEGylation Business Unit of Nektar Therapeutics from May 2007 to February 29, 2008 and served as its Senior Vice President of Business Development and Marketing. Dr. Huh joined Nektar Therapeutics in March 2005. ...
149 Commonwealth DrivePhone: 650-473-7700
Menlo Park, California 94025
Board Members Memberships*
Chairman and Chairman of BiPar Innovation Board
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Scientific Review Committee
Chairman and Member of Nominating & Corporate Governance Committee
Chairman of The Board
Chairman of Scientific Advisory Board and Director
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|